Silence Therapeutics Plc ADR (NASDAQ: SLN) is -25.58% lower on its value in year-to-date trading and has touched a low of $4.82 and a high of $27.72 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SLN stock was last observed hovering at around $5.03 in the last trading session, with the day’s gains setting it 0.09%.
Currently trading at $5.12, the stock is -20.81% and -41.12% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.84 million and changing 1.79% at the moment leaves the stock -69.72% off its SMA200. SLN registered -71.68% loss for a year compared to 6-month loss of -74.79%. The firm has a 50-day simple moving average (SMA 50) of $8.6952 and a 200-day simple moving average (SMA200) of $16.906626.
The stock witnessed a -24.04% gain in the last 1 month and extending the period to 3 months gives it a -72.35%, and is -14.52% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.49% over the week and 9.91% over the month.
Silence Therapeutics Plc ADR (SLN) has around 109 employees, a market worth around $241.72M and $20.57M in sales. Profit margin for the company is -364.60%. Distance from 52-week low is 6.22% and -81.53% from its 52-week high. The company has generated returns on investments over the last 12 months (-59.17%).
with sales reaching $3.73M over the same period.The EPS is expected to shrink by -11.68% this year, but quarterly earnings will post -18.23% year-over-year. Quarterly sales are estimated to grow 77.86% in year-over-year returns.
Silence Therapeutics Plc ADR (SLN) Top Institutional Holders
84.0 institutions hold shares in Silence Therapeutics Plc ADR (SLN), with institutional investors hold 75.57% of the company’s shares. The shares outstanding are 47.21M, and float is at 37.55M with Short Float at 2.62%. Institutions hold 62.77% of the Float.
The top institutional shareholder in the company is TCG CROSSOVER MANAGEMENT, LLC with over 3.3 million shares valued at $62.61 million. The investor’s holdings represent 7.4962% of the SLN Shares outstanding. As of 2024-06-30, the second largest holder is ARTAL GROUP S.A. with 2.78 million shares valued at $52.81 million to account for 6.323 of the shares outstanding. The other top investors are LOMBARD ODIER ASSET MANAGEMENT (USA) CORP which holds 2.41 million shares representing 5.4731% and valued at over $36.76 million, while REDMILE GROUP, LLC holds 4.5821 of the shares totaling 2.01 million with a market value of $38.27 million.
Silence Therapeutics Plc ADR (SLN) Insider Activity
#####
